The field of cancer is a rapidly evolving field with new treatment approaches moving to clinic on a daily basis. Radiation Oncology is no different. It is extremely difficult for a practicing clinician to stay abreast of new developments in cancer care.

The ultimate goal of radiation oncology research is to improve clinical care.  As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.  But despite our best efforts, evidence-based medicine cannot provide 1 clear

This is an education session focused on difficult cases in the use of lung SBRT. It will include a set of challenging cases followed by a short didactic session on each challenging topic. The cases/topics will include: 1) SBRT for a large (>5 cm) primary, node negative tumor.

This journal activity provides practitioners with the knowledge regarding recent treatment advances in lung cancer, including factors that may influence survival in patients with brain metastases with NSCLC and SCLC. It will also quantify how these factors impact survival.

Major decreases in cancer mortality have been driven by improvements in the management of lung cancer. The explanation for these survival improvements is complex but largely driven by the increasing use of systemic therapies in early stage disease such as immunotherapy.

This journal activity provides practitioners with the knowledge needed to better interpret imaging studies performed following lung SBRT and what features should lead to concern for local recurrence.

This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most sub-disciplines of radiation oncology, including sarcomas, pediatrics and the role of radiotherapy in the multidisciplinary management of c

Major decreases in cancer mortality have been driven by improvements in the management of lung cancer. The explanation for these survival improvements is complex but largely driven by the increasing use of systemic therapies in early stage disease such as immunotherapy.

Covid-19 rapidly affected our lives and the life of our patients. Vaccination campaign started in 2021. At least four types of vaccines are widely used in the US (Pfizer, Moderna, Johnson and Johnson and Astra Zeneca).

The course consists of two debates. The first debate consists of two thoracic oncologists with one arguing for the use of surgery and one against the use of surgery for patients with stage III NSCLC.

Pages

Subscribe to RSS - Thoracic